A higher periodic leg movement index (PLMI) predicted less sleep at night in older people with cognitive impairment and sleep disturbance. The study, authored by Kathy C. Continue reading ...
In healthy people, both sleepiness and vigilance show a relationship with core body temperature and skin temperature. When core body temperature is high during the daytime, skin temperature is low, which translates into optimal vigilance. Conversely, when core body temperature is low at night time, skin temperature is high, which correlates to optimal sleep. Continue reading ...
New research shows that cigarette smokers are four times as likely as nonsmokers to report feeling unrested after a night's sleep. The study, appearing in the February issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians (ACCP), also reveals that smokers spend less time in deep sleep and more time in light sleep than nonsmokers, with the greatest differences in sleep patterns seen in the early stages of sleep. Continue reading ...
In one of the largest epidemiologic studies of insomnia among adolescents ever conducted in the United States, this study allows for an estimation of the impact of chronic insomnia on future functioning of adolescents. Youths with insomnia, particularly chronic insomnia, are at greater risk of future somatic and especially psychological problems, the study found. Robert E. Continue reading ...
The sleeping aid Ambien (also called zolpidem) taken 3 to 7 nights per week is safe and effective for at least 6 months in people who suffer from chronic insomnia, according to research published in the medical journal Sleep. Continue reading ...
Four days' exposure to a REM sleep deprivation procedure reduces cell proliferation in the part of the forebrain that contributes to long-term memory of rats, according to a study published in the February 1 issue of the journal SLEEP.The study, authored by Dennis McGinty, PhD, of the V.A. Greater Los Angeles Healthcare System, focused on male Sprague-Dawley rats. Continue reading ...
Older women with sleep-related breathing problems may have a heightened risk of impairments in thinking and memory, a new study suggests. Continue reading ...
Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced that it has initiated a Phase 1 clinical trial with AZ-007 (Staccato(R) zaleplon). AZ-007 is an inhalation product candidate being developed for the treatment of insomnia patients who have difficulty falling asleep, including patients who awake in the middle of the night and have difficulty falling back asleep. This is the first clinical trial of AZ-007 being conducted under an IND filed recently with the U.S. Continue reading ...
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment